These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15894065)

  • 41. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM; Kang TB; Hjorth S; Auerbach SB
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests.
    Takahashi E; Katayama M; Niimi K; Itakura C
    Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
    Chenu F; Guiard BP; Bourin M; Gardier AM
    Behav Brain Res; 2006 Sep; 172(2):256-63. PubMed ID: 16806519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
    Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
    Millan MJ; Dekeyne A
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):579-93. PubMed ID: 17076935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.
    Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA
    J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT).
    Fox MA; Stein AR; French HT; Murphy DL
    Br J Pharmacol; 2010 Feb; 159(4):879-87. PubMed ID: 20128812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality in neonatal rats is increased by moderate prenatal exposure to some monoamine reuptake inhibitors. A brief review.
    Sparenborg S
    Ann N Y Acad Sci; 1998 Jun; 846():423-6. PubMed ID: 9668441
    [No Abstract]   [Full Text] [Related]  

  • 51. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α
    Jiang JL; El Mansari M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109987. PubMed ID: 32474007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
    Rénéric JP; Bouvard M; Stinus L
    Behav Brain Res; 2002 Nov; 136(2):521-32. PubMed ID: 12429415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC; Helsley S; Fiorella D; Rabin RA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
    Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
    Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
    Bourin M; Masse F; Dailly E; Hascoët M
    Pharmacol Biochem Behav; 2005 Jul; 81(3):645-56. PubMed ID: 15961146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes.
    Zhang C; Marek GJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):62-71. PubMed ID: 17728034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems.
    Maj J; Rogóz Z; Dlaboga D; Dziedzicka-Wasylewska M
    J Neural Transm (Vienna); 2000; 107(11):1345-59. PubMed ID: 11145008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
    de Bortoli VC; Nogueira RL; Zangrossi H
    Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of monoamine reuptake inhibitors on cocaine self-administration in rats.
    Tella SR
    Pharmacol Biochem Behav; 1995 Aug; 51(4):687-92. PubMed ID: 7675844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.